Similar Articles
Lessons learned and paths forward: Navigating the social landscape of multiple sclerosis care in the second wave of COVID-19
Nazire Pınar Acar Ozen, Dilara Cilizoglu, Bernanur Toprak, Nartan Demirok, Yeliz Salci, Rana Karabudak, Umut Beşpinar, Aslı Tuncer
DOI: 10.55697/tnd.2025.347
Issue: 2025, Volume 31 - Issue 2
857
585
Alemtuzumab-induced antineutrophil cytoplasmic antibody-associated nephritis in a patient with multiple sclerosis
Furkan Sarıdaş, Saide Elif Güllülü Boz, Belkıs Nihan Coşkun, Emine Rabia Koç, Abdulmecit Yıldız, Berna Aytaç Vuruşkan, Ömer Faruk Turan
DOI: 10.55697/tnd.2024.238
Issue: 2025, Volume 31 - Issue 2
807
558
Redefining multiple sclerosis: 2024 McDonald diagnostic criteria
Hazal Ceren Manazoğlu, Murat Kürtüncü
DOI: 10.55697/tnd.2025.500
Issue: 2025, Volume 31 - Issue 3
4162
2962
Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study
Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva
DOI: 10.55697/tnd.2025.494
Issue: 2025, Volume 31 - Issue 3
824
410
The relationship of pain, disability, and kinesiophobia levels with heart rate variability in patients with migraine: A prospective cross-sectional study
Rabia Tuğba Tekin, Hilal Aslan, Şadiye Gümüşyayla
DOI: 10.55697/tnd.2025.341
Issue: 2025, Volume 31 - Issue 3
572
380
Long-term cladribine experience in relapsing-remitting multiple sclerosis
Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç
DOI: 10.55697/tnd.2025.293
Issue: 2025, Volume 31 - Issue 3
520
398